![Dirk Spitzer's research works | Washington University in St. Louis, Missouri (WUSTL , Wash U) and other places Dirk Spitzer's research works | Washington University in St. Louis, Missouri (WUSTL , Wash U) and other places](https://www.researchgate.net/publication/321991349/figure/fig2/AS:574200872173568@1513911564510/Exploring-human-MSCs-to-serve-as-cellular-carriers-for-TR3-based-cancer-therapy-A-In-a_Q320.jpg)
Dirk Spitzer's research works | Washington University in St. Louis, Missouri (WUSTL , Wash U) and other places
![The targeted SMAC mimetic SW IV-134 augments platinum-based chemotherapy in pre-clinical models of ovarian cancer | BMC Cancer | Full Text The targeted SMAC mimetic SW IV-134 augments platinum-based chemotherapy in pre-clinical models of ovarian cancer | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-022-09367-w/MediaObjects/12885_2022_9367_Fig1_HTML.png)
The targeted SMAC mimetic SW IV-134 augments platinum-based chemotherapy in pre-clinical models of ovarian cancer | BMC Cancer | Full Text
Dirk Spitzer, PhD - Assistant Professor - Washington University School of Medicine, Department of Surgery | LinkedIn
Mesothelin's minimal MUC16 binding moiety converts TR3 into a potent cancer therapeutic via hierarchical binding events at t
Dirk Spitzer, PhD - Assistant Professor - Washington University School of Medicine, Department of Surgery | LinkedIn
![Preclinical Evaluation of an Engineered Single-Chain Fragment Variable-Fragment Crystallizable Targeting Human CD44 | Journal of Nuclear Medicine Preclinical Evaluation of an Engineered Single-Chain Fragment Variable-Fragment Crystallizable Targeting Human CD44 | Journal of Nuclear Medicine](https://jnm.snmjournals.org/sites/default/files/highwire/jnumed/62/1.cover-source.jpg)
Preclinical Evaluation of an Engineered Single-Chain Fragment Variable-Fragment Crystallizable Targeting Human CD44 | Journal of Nuclear Medicine
![Dirk Spitzer's research works | Washington University in St. Louis, Missouri (WUSTL , Wash U) and other places Dirk Spitzer's research works | Washington University in St. Louis, Missouri (WUSTL , Wash U) and other places](https://www.researchgate.net/publication/303707779/figure/fig5/AS:381337165942787@1467929273235/sW-V-49-competes-for-the-sigma-2-receptor-and-enacts-erastin-mediated-death-by-inhibition_Q320.jpg)
Dirk Spitzer's research works | Washington University in St. Louis, Missouri (WUSTL , Wash U) and other places
![Dirk Spitzer's research works | Washington University in St. Louis, Missouri (WUSTL , Wash U) and other places Dirk Spitzer's research works | Washington University in St. Louis, Missouri (WUSTL , Wash U) and other places](https://www.researchgate.net/profile/M-Anna-Kowalska/publication/40045328/figure/fig5/AS:277075215831048@1443071287749/Pharmacokinetics-of-125-I-anti-GPA-scFv-PA-fusion-protein-versus_Q320.jpg)
Dirk Spitzer's research works | Washington University in St. Louis, Missouri (WUSTL , Wash U) and other places
Dirk Spitzer, PhD - Assistant Professor - Washington University School of Medicine, Department of Surgery | LinkedIn
Lysosomal Membrane Permeabilization is an Early Event in Sigma-2 Receptor Ligand Mediated Cell Death in Pancreatic Cancer
![Targeted pancreatic cancer therapy with the small molecule drug conjugate SW IV‐134 - Hashim - 2014 - Molecular Oncology - Wiley Online Library Targeted pancreatic cancer therapy with the small molecule drug conjugate SW IV‐134 - Hashim - 2014 - Molecular Oncology - Wiley Online Library](https://febs.onlinelibrary.wiley.com/cms/asset/b3f895c9-5e8c-4b14-8ce0-b900f6c65758/mol2201485956-fig-0006-m.jpg)